Related Experiment Video
Updated: May 24, 2025

Recording and Analysis of Circadian Rhythms in Running-wheel Activity in Rodents
Published on: January 24, 2013
Circadian rhythm defects in Prader-Willi syndrome neurons
A Kaitlyn Victor1, Tayler Hedgecock2, Chidambaram Ramanathan3
1Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Insights
Prader-Willi syndrome (PWS) neurons show disrupted circadian rhythms. The drug longdaysin normalized the shorter circadian period in PWS neurons, offering a potential therapeutic avenue for sleep dysfunction.
Area of Science:
- Neuroscience
- Genetics
- Chronobiology
Background:
- Prader-Willi syndrome (PWS) is a genetic imprinting disorder affecting neurodevelopment and causing intellectual disability and autism risk.
- PWS is linked to the loss of paternal gene expression in the 15q11.2-q13 region, impacting genes like MAGEL2.
- Patients with PWS frequently experience sleep disorders, and animal models show disrupted circadian rhythms.
Purpose of the Study:
- To investigate circadian clock function in neurons derived from Prader-Willi syndrome patients.
- To establish an in vitro model for studying PWS-related circadian rhythm disruptions.
- To explore potential therapeutic interventions for PWS circadian dysfunction.
Main Methods:
- Dental pulp stem cells (DPSCs) from PWS patients and controls were differentiated into neurons.
- A Per2 promoter-driven luciferase reporter (Per2:luc) was introduced to assess circadian rhythms via bioluminescence.
- Kinetic measurements of luciferase activity were performed over several days to analyze circadian period length.
Main Results:
- Significant differences in circadian period length were observed between PWS neurons and control neurons.
- Treatment with the small molecule longdaysin effectively lengthened the shorter circadian period in PWS neurons.
- The study successfully modeled PWS circadian dysfunction in vitro.
Conclusions:
- Neurons derived from PWS patients exhibit altered circadian clock function.
- Longdaysin demonstrates potential as a therapeutic agent for correcting circadian rhythm abnormalities in PWS.
- This research provides a foundation for developing drug discovery assays for PWS-related sleep and circadian disorders.
Abstract:
Prader-Willi syndrome (PWS) is a neurodevelopmental disorder characterized by a spectrum of symptoms, including developmental delay, intellectual disability, and increased risk of autism. PWS is an imprinting disorder caused by the loss of paternal expression of critical genes in the 15q11.2-q13 region, including MAGEL2, SNRPN/SNURF, and SNORD116. PWS patients often suffer from various sleep disorders, including sleep-disordered breathing and central hypersomnolence. Mouse models of PWS also exhibit disruptions in circadian rhythms and sleep. In cultured cells, Magel2 was shown to regulate the expression of Bmal1 and Per2, two core clock genes involved in the circadian rhythm regulatory process. Here, we investigated the circadian clock function in neurons derived from dental pulp stem cells (DPSCs) of PWS patients and neurotypical controls. To study the circadian rhythms of PWS patients in vitro, we introduced the Per2 promoter-driven luciferase reporter (Per2:luc) to these DPSC cell lines to assess their circadian rhythm by bioluminescence. These Per2:luc cells were differentiated for 4 weeks to mature neuronal reporter cell lines, followed by kinetic measurements of luciferase activity over several days. We observed significant differences in circadian period length between PWS neurons and controls. Moreover, treatment with the small molecule longdaysin effectively lengthened the period length of PWS neurons with a shorter period length, as anticipated based on the mechanism of action of this compound. This work lays the foundation for a deeper understanding of PWS pathophysiology and represents a critical first step toward developing high-throughput assays for drug discovery targeting circadian and sleep dysfunction in PWS.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Neural Regulation

